View in EDS

Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Saved in:
Bibliographic Details
Title: Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.
Authors: Leung E; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Coastal Program for Rare Inflammatory Diseases, Nova Scotia Health Innovation Hub, Halifax, Nova Scotia, Canada., Fragola NR; Every Cure, Philadelphia, Pennsylvania, USA., Sharp EW; Every Cure, Philadelphia, Pennsylvania, USA., Harrison RA; Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Peterson E; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada., Varghese J; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada., Jackson S; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada., You XJ; Division of Hematology, McGill University, Montreal, Quebec, Canada., VanderVeer E; Division of Hematology, British Columbia Cancer Agency, Surrey, British Columbia, Canada., Trinder M; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Sutherland A; Division of Dermatology, Dalhousie University, Halifax, Nova Scotia, Canada., Dutz J; Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Kaniewski P; Every Cure, Philadelphia, Pennsylvania, USA., McClain KL; Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA., Abla O; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada., Fajgenbaum DC; Every Cure, Philadelphia, Pennsylvania, USA.; Division of Translational Medicine & Human Genetics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chen LYC; Coastal Program for Rare Inflammatory Diseases, Nova Scotia Health Innovation Hub, Halifax, Nova Scotia, Canada.; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.
Source: American journal of hematology [Am J Hematol] 2026 Jul; Vol. 101 (7), pp. 1478-1483. Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article; Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41928050
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leung+E%22">Leung E</searchLink>; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Coastal Program for Rare Inflammatory Diseases, Nova Scotia Health Innovation Hub, Halifax, Nova Scotia, Canada.<br /><searchLink fieldCode="AU" term="%22Fragola+NR%22">Fragola NR</searchLink>; Every Cure, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Sharp+EW%22">Sharp EW</searchLink>; Every Cure, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+RA%22">Harrison RA</searchLink>; Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Peterson+E%22">Peterson E</searchLink>; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Varghese+J%22">Varghese J</searchLink>; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Jackson+S%22">Jackson S</searchLink>; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22You+XJ%22">You XJ</searchLink>; Division of Hematology, McGill University, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22VanderVeer+E%22">VanderVeer E</searchLink>; Division of Hematology, British Columbia Cancer Agency, Surrey, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Trinder+M%22">Trinder M</searchLink>; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Sutherland+A%22">Sutherland A</searchLink>; Division of Dermatology, Dalhousie University, Halifax, Nova Scotia, Canada.<br /><searchLink fieldCode="AU" term="%22Dutz+J%22">Dutz J</searchLink>; Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Kaniewski+P%22">Kaniewski P</searchLink>; Every Cure, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22McClain+KL%22">McClain KL</searchLink>; Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Abla+O%22">Abla O</searchLink>; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Fajgenbaum+DC%22">Fajgenbaum DC</searchLink>; Every Cure, Philadelphia, Pennsylvania, USA.; Division of Translational Medicine & Human Genetics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Chen+LYC%22">Chen LYC</searchLink>; Coastal Program for Rare Inflammatory Diseases, Nova Scotia Health Innovation Hub, Halifax, Nova Scotia, Canada.; Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2026 Jul; Vol. 101 (7), pp. 1478-1483. <i>Date of Electronic Publication: </i>2026 Apr 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41928050
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.70309
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1478
    Titles:
      – TitleFull: Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leung E
      – PersonEntity:
          Name:
            NameFull: Fragola NR
      – PersonEntity:
          Name:
            NameFull: Sharp EW
      – PersonEntity:
          Name:
            NameFull: Harrison RA
      – PersonEntity:
          Name:
            NameFull: Peterson E
      – PersonEntity:
          Name:
            NameFull: Varghese J
      – PersonEntity:
          Name:
            NameFull: Jackson S
      – PersonEntity:
          Name:
            NameFull: You XJ
      – PersonEntity:
          Name:
            NameFull: VanderVeer E
      – PersonEntity:
          Name:
            NameFull: Trinder M
      – PersonEntity:
          Name:
            NameFull: Sutherland A
      – PersonEntity:
          Name:
            NameFull: Dutz J
      – PersonEntity:
          Name:
            NameFull: Kaniewski P
      – PersonEntity:
          Name:
            NameFull: McClain KL
      – PersonEntity:
          Name:
            NameFull: Abla O
      – PersonEntity:
          Name:
            NameFull: Fajgenbaum DC
      – PersonEntity:
          Name:
            NameFull: Chen LYC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 101
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1